Physician profile
Christopher Skillern
NPI 1205936697
$15,445.01
in general payments reported to CMS, 2019-2025
25 companies · $4,775 in 2025
The $4,775 reported for 2025 was more than what 84% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,652 · 2020: $42.08 · 2021: $383 · 2022: $1,591 · 2023: $2,482 · 2024: $4,521 · 2025: $4,775.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,102 · Long Term Medical Supply Or Device Loan: $3,750 · Consulting Fee: $2,925.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,102.08 |
| Long Term Medical Supply Or Device Loan | $3,750.00 |
| Consulting Fee | $2,925.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $4,628.23 | 2023-2025 | (9520) Igt Devices Undivided, (Dd1) Duo Hybrid, Phoenix |
| Angiodynamics, INC. | $3,750.00 | 2025 | Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $2,477.56 | 2021-2025 | Concertotm, Endurant Iis, Abre |
| W. L. Gore & Associates, INC. | $1,413.87 | 2019 | |
| Imperative Care, INC | $849.19 | 2023-2024 | Prodigy Catheter |
| Inari Medical, INC. | $644.41 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Reflow Medical INC | $426.87 | 2024-2025 | |
| Silk Road Medical, INC. | $233.01 | 2021-2022 | |
| Boston Scientific Corporation | $184.12 | 2023-2024 | Wavewriter Alpha Prime 16, Varithena Administration Pack |
| Penumbra, INC. | $150.00 | 2021 | |
| Medtronic Vascular, INC. | $130.10 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $107.74 | 2019-2023 | Xarelto |
| Pfizer INC. | $82.15 | 2019-2021 | |
| Lemaitre Vascular, INC. | $70.78 | 2022-2024 | Trivex System |
| Vertex Pharmaceuticals Incorporated | $50.03 | 2024-2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $48.88 | 2022-2023 | Barostim Neo System |
| Tactile Systems Technology INC | $29.70 | 2020-2021 | |
| Getinge USA Sales, LLC | $26.69 | 2019 | |
| Fresenius USA Marketing, INC. | $23.85 | 2025 | Velphoro |
| Truvic Medical, INC. | $23.54 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $21.20 | 2025 | Exparel |
| Cagent Vascular INC | $21.00 | 2025 | Serrantor |
| Inspiremd LTD | $20.61 | 2025 | Cguard Prime Carotid Stent System |
| Endologix LLC | $16.31 | 2019 | |
| Organogenesis INC. | $15.17 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Skillern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.